S1 Dataset - by Anotida R. Hove (20513536)

“…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”

EBBS frequencies, N = 517. by Anotida R. Hove (20513536)

“…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”

EBBS summative indices, N = 517. by Anotida R. Hove (20513536)

“…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”

Exercise Habits, N = 517. by Anotida R. Hove (20513536)

“…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”

Adjusted odds ratios. by Anotida R. Hove (20513536)

“…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”

Obstetric and health characteristics, N = 517. by Anotida R. Hove (20513536)

“…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”

Physical activity summative indices, N = 517. by Anotida R. Hove (20513536)

“…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”

Sociodemographic characteristics, N = 517. by Anotida R. Hove (20513536)

“…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”

Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis by Guoli Yan (4591687)

“…Fixed-effects and random-effects meta-analyses were performed to pool the relative risks (RRs), hazard ratios (HRs) and weighted mean difference (WMD). Publication bias and heterogeneity were examined. …”

The effects of metformin, donepezil, insulin glargine, and glibenclamide on brain biomarkers: Amyloid β 42, nitric oxide, acetylcholinesterase, malondialdehyde, β secretase, and pM... by Shatw Khalid Ali (13020885)

GSH evokes increase in the extracellular GABA levels in chick retinal tissue and in mixed neuronal-glial cells in culture. by Hercules R. Freitas (3174633)

“…<p>GSH treatment evokes GABA release in chick retinal tissue or in cells in culture (A) Extracellular GABA levels were measured in E11 avian retina upon incubation with 1–5mM GSH for 10 min. Values are means ± SD from two independent experiments (ANOVA-Tukey *<i>p</i> < 0.01 vs. control, n ≥ 4). …”

List of antibodies used in this study. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

List of primers used in this study. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

Striking image. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

Study subjects. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

List of reagents used in this study. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

Table_2_Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer.DOCX by Christian Schwedler (4963723)

“…<p>The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been affecting the world since January 2020 and has caused millions of deaths. …”

Image_1_Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer.JPEG by Christian Schwedler (4963723)

“…<p>The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been affecting the world since January 2020 and has caused millions of deaths. …”

Image_2_Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer.JPEG by Christian Schwedler (4963723)

“…<p>The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been affecting the world since January 2020 and has caused millions of deaths. …”

Image_3_Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer.JPEG by Christian Schwedler (4963723)

“…<p>The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been affecting the world since January 2020 and has caused millions of deaths. …”